Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
NovaBay Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2026 | $15.80M | $15.78M - $15.82M | -$4.28M | -$1.90 | 1 |
| Dec 2025 | $12.00M | $12.00M - $12.00M | -$3.25M | -$4.30 | 1 |
| Dec 2024 | $10.00M | $10.00M - $10.00M | -$2.71M | -$16.30 | 1 |
| Dec 2023 | $13.88M | $13.88M - $13.88M | -$3.76M | -$30.447 | 1 |
| Dec 2022 | $14.23M | $14.23M - $14.23M | -$8.52M | -$173.25 | 1 |
| Dec 2021 | $9.13M | $9.13M - $9.13M | -$5.47M | -$220.50 | 1 |
| Dec 2020 | $10.50M | $10.50M - $10.50M | -$6.29M | -$392.00 | 1 |
| Dec 2019 | $6.95M | $6.95M - $6.95M | -$4.16M | -$514.50 | 1 |
| Dec 2018 | $12.64M | $12.64M - $12.64M | -$7.57M | -$502.25 | 1 |
| Dec 2017 | $17.88M | $17.88M - $17.88M | -$10.71M | -$702.333 | 1 |
| Dec 2016 | $12.04M | $12.04M - $12.04M | -$7.22M | -$2,070.25 | 1 |
| Dec 2015 | $3.90M | $3.90M - $3.90M | -$2.34M | -$7,656.25 | 1 |